NMTC logo

NMTC Cash From Financing

Annual CFF

$7.27 M
-$129.50 K-1.75%

September 30, 2024

Summary

Performance

1-Year Change

-1.75%

3-Year Change

-36.98%

5-Year Change

+26.06%

15-Year Change

+326.62%

NMTC Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

53.32%
NMTC annual cash flow from financing activities is higher than 53.32% of companies in Healthcare sector

High & Low

All-time High

$12.02 M
NMTC annual cash flow from financing activities is currently -39.54% below its historical high of $12.02 million

3-Year Low

$7.27 M
NMTC annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
NMTC previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
NMTC next annual earnings announcement has not yet been scheduled

OtherNMTCcash flowmetrics:

Annual CFI

-$120.20 K
NMTC annual cash flow from investing activities is -$120.20 thousand

Annual CFO

-$11.01 M
NMTC annual cash flow from operations is -$11.01 million

Annual FCF

-$11.13 M
NMTC annual free cash flow is -$11.13 million

Annual CAPEX

$120.20 K
NMTC annual capital expenditures is $120.20 thousand

Quarterly CFF

$2.54 M
+$983.40 K+63.02%

September 30, 2024

Summary

Performance

3-Month Change

+63.02%

1-Year Change

-51%

3-Year Change

-78.84%

5-Year Change

-15.73%

NMTC Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

72.67%
NMTC quarterly cash flow from financing activities is higher than 72.67% of companies in Healthcare sector

High & Low

All-time High

$12.02 M
NMTC quarterly cash flow from financing activities is currently -78.84% below its historical high of $12.02 million

3-Year Low

-$15.70 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NMTC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 12, 2025
NMTC next earnings announcement is scheduled for Feb 12, 2025

OtherNMTCcash flowmetrics:

Quarterly CFI

-$36.90 K
NMTC quarterly cash flow from investing activities is -$36.90 thousand

Quarterly CFO

-$2.67 M
NMTC quarterly cash flow from operations is -$2.67 million

Quarterly FCF

-$2.70 M
NMTC quarterly free cash flow is -$2.70 million

Quarterly CAPEX

$36.90 K
NMTC quarterly capital expenditures is $36.90 thousand

TTM CFF

$7.27 M
-$2.65 M-26.70%

September 30, 2024

Summary

Performance

3-Month Change

-26.7%

1-Year Change

-1.75%

3-Year Change

-60.84%

5-Year Change

-6.18%

NMTC TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.39%
NMTC TTM cash flow from financing activities is higher than 48.39% of companies in Healthcare sector

High & Low

All-time High

$18.56 M
NMTC TTM cash flow from financing activities is currently -60.84% below its historical high of $18.56 million

3-Year Low

-$16.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NMTC previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 12, 2025
NMTC next earnings announcement is scheduled for Feb 12, 2025

OtherNMTCcash flowmetrics:

TTM CFI

-$120.20 K
NMTC TTM cash flow from investing activities is -$120.20 thousand

TTM CFO

-$11.01 M
NMTC TTM cash flow from operations is -$11.01 million

TTM FCF

-$11.13 M
NMTC TTM free cash flow is -$11.13 million

TTM CAPEX

$120.20 K
NMTC TTM capital expenditures is $120.20 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

NMTC Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.8%-51.0%-1.8%
3 y3 years-37.0%-78.8%-60.8%
5 y5 years+26.1%-15.7%-6.2%

NMTC Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-39.5%at low-78.8%>+9999.0%-60.8%>+9999.0%
5 y5-year-39.5%+26.1%-78.8%>+9999.0%-60.8%>+9999.0%
alltimeall time-39.5%>+9999.0%-78.8%>+9999.0%-60.8%>+9999.0%

NeuroOne Medical Technologies Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
$7.27 M(-1.8%)
$2.54 M(+63.0%)
$7.27 M(-26.7%)
Jun 2024
-
$1.56 M(-20.4%)
$9.92 M(-0.0%)
Mar 2024
-
$1.96 M(+62.7%)
$9.92 M(+15.1%)
Dec 2023
-
$1.21 M(-76.8%)
$8.62 M(+16.5%)
Sep 2023
$7.40 M(-38.5%)
$5.19 M(+232.6%)
$7.40 M(+235.2%)
Jun 2023
-
$1.56 M(+135.8%)
$2.21 M(+241.5%)
Mar 2023
-
$662.00 K(-4316.6%)
$646.30 K(-4139.4%)
Dec 2022
-
-$15.70 K(<-9900.0%)
-$16.00 K(-100.1%)
Sep 2022
$12.02 M(+4.2%)
$0.00(0.0%)
$12.02 M(+0.2%)
Jun 2022
-
$0.00(-100.0%)
$12.00 M(-0.3%)
Mar 2022
-
-$300.00(-100.0%)
$12.03 M(-35.2%)
Dec 2021
-
$12.02 M(<-9900.0%)
$18.56 M(+60.9%)
Sep 2021
$11.53 M(+57.5%)
-$25.00 K(-169.6%)
$11.53 M(-0.2%)
Jun 2021
-
$35.90 K(-99.4%)
$11.56 M(-27.1%)
Mar 2021
-
$6.53 M(+30.6%)
$15.85 M(+70.4%)
Dec 2020
-
$5.00 M(<-9900.0%)
$9.30 M(+27.0%)
Sep 2020
$7.32 M(+27.0%)
-$3900.00(-100.1%)
$7.32 M(-2.2%)
Jun 2020
-
$4.33 M(<-9900.0%)
$7.49 M(+95.3%)
Mar 2020
-
-$16.90 K(-100.6%)
$3.84 M(-50.5%)
Dec 2019
-
$3.02 M(+1771.5%)
$7.75 M(+34.4%)
Sep 2019
$5.77 M(+153.9%)
$161.30 K(-76.0%)
$5.77 M(+2.9%)
Jun 2019
-
$672.10 K(-82.8%)
$5.61 M(-1.5%)
Mar 2019
-
$3.90 M(+275.7%)
$5.69 M(+138.7%)
Dec 2018
-
$1.04 M(+37.2%)
$2.38 M(+6.5%)
Sep 2018
$2.27 M(+33.3%)
-
-
Jun 2018
-
$756.00 K(+28.1%)
$2.24 M(+13.1%)
Mar 2018
-
$590.00 K(-8.8%)
$1.98 M(+16.1%)
Dec 2017
$1.70 M
$646.60 K(+163.9%)
$1.70 M(+58.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
$245.00 K(-50.7%)
$1.08 M(+30.7%)
Jun 2017
-
$497.40 K(+57.9%)
$825.40 K(+145.5%)
Mar 2017
-
$315.10 K(+1393.4%)
$336.20 K(+1493.4%)
Dec 2016
$21.10 K(-29.7%)
$21.10 K(-357.3%)
$21.10 K(+245.9%)
Sep 2016
-
-$8200.00(-200.0%)
$6100.00(-65.3%)
Jun 2016
-
$8200.00(>+9900.0%)
$17.60 K(+69.2%)
Mar 2016
-
$0.00(-100.0%)
$10.40 K(-65.3%)
Dec 2015
$30.00 K(+15.8%)
$6100.00(+84.8%)
$30.00 K(-7.7%)
Sep 2015
-
$3300.00(+230.0%)
$32.50 K(-30.0%)
Jun 2015
-
$1000.00(-94.9%)
$46.40 K(+2.2%)
Mar 2015
-
$19.60 K(+127.9%)
$45.40 K(+76.0%)
Dec 2014
$25.90 K(+5.7%)
$8600.00(-50.0%)
$25.80 K(+31.0%)
Sep 2014
-
$17.20 K(>+9900.0%)
$19.70 K(+203.1%)
Jun 2014
-
$0.00(0.0%)
$6500.00(-62.9%)
Mar 2014
-
$0.00(-100.0%)
$17.50 K(-28.6%)
Dec 2013
$24.50 K(+2350.0%)
$2500.00(-37.5%)
$24.50 K(+6.5%)
Sep 2013
-
$4000.00(-63.6%)
$23.00 K(+21.1%)
Jun 2013
-
$11.00 K(+57.1%)
$19.00 K(+137.5%)
Mar 2013
-
$7000.00(+600.0%)
$8000.00(+700.0%)
Dec 2012
$1000.00(-96.9%)
$1000.00(>+9900.0%)
$1000.00(-95.9%)
Sep 2012
-
$0.00(0.0%)
$24.40 K(-15.0%)
Jun 2012
-
$0.00(0.0%)
$28.70 K(-10.9%)
Mar 2012
-
$0.00(-100.0%)
$32.20 K(0.0%)
Dec 2011
$32.10 K(+146.9%)
$24.40 K(+467.4%)
$32.20 K(+312.8%)
Sep 2011
-
$4300.00(+22.9%)
$7800.00(+122.9%)
Jun 2011
-
$3500.00(>+9900.0%)
$3500.00(>+9900.0%)
Mar 2011
-
$0.00
$0.00
Dec 2010
$13.00 K
-
-

FAQ

  • What is NeuroOne Medical Technologies annual cash flow from financing activities?
  • What is the all time high annual CFF for NeuroOne Medical Technologies?
  • What is NeuroOne Medical Technologies annual CFF year-on-year change?
  • What is NeuroOne Medical Technologies quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for NeuroOne Medical Technologies?
  • What is NeuroOne Medical Technologies quarterly CFF year-on-year change?
  • What is NeuroOne Medical Technologies TTM cash flow from financing activities?
  • What is the all time high TTM CFF for NeuroOne Medical Technologies?
  • What is NeuroOne Medical Technologies TTM CFF year-on-year change?

What is NeuroOne Medical Technologies annual cash flow from financing activities?

The current annual CFF of NMTC is $7.27 M

What is the all time high annual CFF for NeuroOne Medical Technologies?

NeuroOne Medical Technologies all-time high annual cash flow from financing activities is $12.02 M

What is NeuroOne Medical Technologies annual CFF year-on-year change?

Over the past year, NMTC annual cash flow from financing activities has changed by -$129.50 K (-1.75%)

What is NeuroOne Medical Technologies quarterly cash flow from financing activities?

The current quarterly CFF of NMTC is $2.54 M

What is the all time high quarterly CFF for NeuroOne Medical Technologies?

NeuroOne Medical Technologies all-time high quarterly cash flow from financing activities is $12.02 M

What is NeuroOne Medical Technologies quarterly CFF year-on-year change?

Over the past year, NMTC quarterly cash flow from financing activities has changed by -$2.65 M (-51.00%)

What is NeuroOne Medical Technologies TTM cash flow from financing activities?

The current TTM CFF of NMTC is $7.27 M

What is the all time high TTM CFF for NeuroOne Medical Technologies?

NeuroOne Medical Technologies all-time high TTM cash flow from financing activities is $18.56 M

What is NeuroOne Medical Technologies TTM CFF year-on-year change?

Over the past year, NMTC TTM cash flow from financing activities has changed by -$129.50 K (-1.75%)